Testing Q-Cells for ALS
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This study tests a new treatment called Q-Cells®, which are special cells injected into the spinal cord to see if they can help slow ALS. It is for people with ALS who have a caregiver and are healthy enough to undergo the procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 80 years old
- You have been diagnosed with ALS within the last 4 years
- You have a caregiver who can help you get to the study center (within about 3 hours drive)
- Your breathing test (FVC) is at least 65% of normal for your age
- You have not had a stem cell transplant before
- You are not allergic to eggs, chicken, or certain immune-suppressing medicines
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called VTx-002 to see if it is safe and tolerable for people with ALS. You may be able to join if you have had symptoms for less than 18 months and have a caregiver who can help.
This study tests an experimental drug called PLL001 for people with ALS. It aims to see if the drug is safe and if it can slow the progression of the disease. You may be a good fit if you have been recently diagnosed and are still in the early stages of ALS.
This study uses quantitative computed tomography (QCT), a special type of CT scan, to help diagnose ALS, understand how it affects the body, and track its progression over time. It is for people who may have ALS and meet specific diagnostic criteria.
This trial studies an experimental drug called LTX-002 for people with ALS. It aims to see if the drug is safe and can slow down the disease.
This trial tests RAPA-501, a treatment made using your own immune cells, to slow progression of ALS. It may help by changing how your immune system responds in ALS.
This study tests a supplement called acetyl-L-carnitine (ALCAR) to see if it can slow the progression of ALS. It is for people in the early stages of the disease who are already taking riluzole and have good lung and muscle function.
Hear when a new Amyotrophic Lateral Sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.